American Vanguard Corporation (NYSE:AVD) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Tuesday.

According to Zacks, “AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms. “

Other analysts have also issued reports about the company. BidaskClub upgraded American Vanguard Corporation from a “strong sell” rating to a “sell” rating in a report on Thursday, August 10th. Roth Capital set a $28.00 target price on American Vanguard Corporation and gave the company a “buy” rating in a research note on Sunday. One analyst has rated the stock with a sell rating, two have assigned a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $22.67.

Shares of American Vanguard Corporation (NYSE AVD) traded up 0.42% on Tuesday, reaching $23.70. 123,202 shares of the company’s stock were exchanged. The company has a market capitalization of $705.86 million, a P/E ratio of 48.37 and a beta of 1.26. The firm’s 50 day moving average price is $20.85 and its 200-day moving average price is $18.39. American Vanguard Corporation has a 12 month low of $14.20 and a 12 month high of $23.80.

American Vanguard Corporation (NYSE:AVD) last posted its quarterly earnings results on Monday, July 31st. The basic materials company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.14 by $0.01. American Vanguard Corporation had a net margin of 4.56% and a return on equity of 5.10%. The business had revenue of $77.90 million for the quarter, compared to analysts’ expectations of $77.71 million. During the same period in the previous year, the company posted $0.11 EPS. American Vanguard Corporation’s revenue was up 7.2% on a year-over-year basis. On average, equities analysts anticipate that American Vanguard Corporation will post $0.65 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This story was reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another publication, it was stolen and republished in violation of United States and international trademark & copyright laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/10/03/american-vanguard-corporation-avd-downgraded-by-zacks-investment-research-to-hold.html.

In other American Vanguard Corporation news, insider David` T. Johnson sold 6,000 shares of the business’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $19.00, for a total value of $114,000.00. Following the completion of the sale, the insider now directly owns 35,040 shares of the company’s stock, valued at $665,760. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 4.70% of the stock is owned by insiders.

Several institutional investors have recently added to or reduced their stakes in the company. Kennedy Capital Management Inc. lifted its stake in shares of American Vanguard Corporation by 1,158.7% in the 2nd quarter. Kennedy Capital Management Inc. now owns 374,744 shares of the basic materials company’s stock valued at $6,464,000 after purchasing an additional 344,971 shares during the last quarter. JPMorgan Chase & Co. increased its position in American Vanguard Corporation by 106.1% during the first quarter. JPMorgan Chase & Co. now owns 539,145 shares of the basic materials company’s stock worth $8,949,000 after buying an additional 277,593 shares during the last quarter. Walthausen & Co. LLC increased its position in American Vanguard Corporation by 57.7% during the second quarter. Walthausen & Co. LLC now owns 701,722 shares of the basic materials company’s stock worth $12,105,000 after buying an additional 256,637 shares during the last quarter. Heartland Advisors Inc. increased its position in American Vanguard Corporation by 32.6% during the second quarter. Heartland Advisors Inc. now owns 871,469 shares of the basic materials company’s stock worth $15,033,000 after buying an additional 214,141 shares during the last quarter. Finally, Vanguard Group Inc. increased its position in American Vanguard Corporation by 5.2% during the first quarter. Vanguard Group Inc. now owns 2,430,201 shares of the basic materials company’s stock worth $40,342,000 after buying an additional 119,462 shares during the last quarter. Institutional investors and hedge funds own 76.87% of the company’s stock.

About American Vanguard Corporation

American Vanguard Corporation operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico SA de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC C.V.

Get a free copy of the Zacks research report on American Vanguard Corporation (AVD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for American Vanguard Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard Corporation and related companies with MarketBeat.com's FREE daily email newsletter.